JULIE JULIAN: Open Payments
NPI 1639395866 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,644 in 182 payments from 25 companies in 2025. Trend: 2023 $2,968 · 2024 $2,912 · 2025 $2,644
Food & beverage: $2,644
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $564 |
| PFIZER INC. | 23 | $279 |
| Novo Nordisk Inc | 15 | $234 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $222 |
| Lilly USA, LLC | 11 | $209 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $186 |
| AstraZeneca Pharmaceuticals LP | 8 | $185 |
| Amgen Inc. | 19 | $174 |
| Teva Pharmaceuticals USA, Inc. | 4 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $73 |
Products named: CAPLYTA, UBRELVY, VRAYLAR, XIFAXAN, NURTEC ODT, QULIPTA, Ozempic, JARDIANCE.
Industry payments across VA — which companies pay providers there.
